Contact:
4008465777
×
R&D Progress
Guided by the philosophy of "building a global brand through continuous innovation", we constantly optimize our product mix and enrich our research pipelines. We devote ourselves to the development of medicines for diabetes and other endocrine disorders diseases, in a bid to enhance our market competitiveness and lead the domestic industry.
Milestones
-
1985
Fresh Ginseng oral liquid
Product Pipeline
| Product Name | Indications | Preclinical | IND | Clinical | NDA | |
|---|---|---|---|---|---|---|
| Mixed protamine zinc recombinant human insulin lispro injection 25R | Diabetes requiring insulin therapy | |||||
| Mixed protamine zinc recombinant human insulin lispro injection 50R | Diabetes requiring insulin therapy | |||||
| Insulin Degludec Injection | Type 2 diabetes in adults | |||||
| Insulin Degludec and Liraglutide Injection | Type 2 diabetes in adults | |||||
| Ultra-fast Insulin Lispro Injection（BC Lispro） | Type 1 diabetes in adults | |||||
| Semaglutide Injection | Type 2 diabetes in adults | |||||
| THDBH161 | Acute gouty arthritis | |||||
| SGLT1/SGLT2/DPP4 Inhibitor | Type 2 diabetes in adults | |||||
| THDBH110/111 | Type 2 diabetes in adults | |||||
| THDBH120 | Type 2 diabetes in adults | |||||
| THDBH120 | Obesity | |||||
| URAT1 Inhibitor | Gout/hyperuricemia | |||||
| THDBH150/151 | Gout/hyperuricemia |